# Infinity Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/infinity-bio

- Industry: Biotechnology
- Headquarters: Baltimore, US
- Website: www.infinitybio.com
- Total disclosed funding: $10M
- Latest round: Series A (Jun 13, 2025)
- Investors on record: 4

## About

Based in Maryland, US, and founded in 2023, Infinity Bio, Inc. operates as a health-tech company that provides an online platform that offers antibody profiling solutions for medical applications. In June 2025, Infinity Bio, Inc. raised USD 8 million in Series A funding led by Illumina Ventures, with participation from Propel Baltimore Fund, PTX Capital, and Blackbird Labs, Inc. also participated in the round. The company provides antibody profiling solutions through its health-tech platform for medical applications. The company will use the June 2025 funding for platform innovation and for further development.

## Funding rounds

- Series A, Jun 13, 2025, $8M — TCP Venture Capital, Illumina Ventures, PTX Capital, Blackbird Laboratories
- Seed, Jun 3, 2024, $2M — PTX Capital

## Investors

- PTX Capital (https://capitalatlas.ai/funds/ptx-capital) — Seed, Series A
- TCP Venture Capital (https://capitalatlas.ai/funds/tcp-venture-capital) — Series A
- Illumina Ventures (https://capitalatlas.ai/funds/illumina-ventures) — Series A
- Blackbird Laboratories (https://capitalatlas.ai/funds/blackbird-laboratories) — Series A